5-Minute Market Rundown(2)
Bernie's Content(2)
By the Numbers(2)
Indexes and ETFs(6)
Intraday Option Activity(3)
Quantitative Analysis(1)
Stock Market News(2)
Technical Analysis(1)

9/12/2017 3:55 PM
September is historically been a weak month for the Health Care Select Sector SPDR Fund (XLV). According to data from Schaeffer's Quantitative Analyst Chris Prybal, the fund has averaged a 1.7% loss i...
6/27/2017 1:37 PM
Biotech stocks have been hot lately, with the SPDR S&P Biotech ETF (XBI) flirting with annual highs. What's more, the exchange-traded fund (ETF) is one of the best to own in the month of July, histor...
6/26/2017 2:23 PM
As of this writing, senators still have some haggling to do in order to ensure the passage of a revamped healthcare bill next week -- but the action in the Health Care Select Sector SPDR Fund (XLV) ...
3/24/2017 1:25 PM
All eyes were on Washington, D.C., this week, as President Donald Trump and House Republicans scrambled to find the votes to pass a healthcare bill repealing Obamacare. The vote, initially slated for...
3/23/2017 12:07 PM
After a drop at the open, stocks are trading higher today ahead of a key congressional vote over the healthcare bill to repeal and replace Obamacare. Ahead of the critical House vote on the American ...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.

Partner Center